Average parameters in bioavailability studies: An application to slow-release amitriptyline formulation

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 1998, Pages 160-165

  Fagiolino, P ^a   Vazquez M ^a   Savio, E ^a   Dominguez L ^a   Aiache, J M ^b   Beyssac, E ^b  

^a Faculty of Chemistry   (Uruguay)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Amitriptyline; Average parameters; Bioavailability; Slow release formulation

Indexed keywords

AMITRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AREA UNDER THE CURVE; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; VARIANCE;

EID: 0031687247     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189333     Document Type: Conference Paper

References (6)

1. Steinijans V.W. (1990): Pharmacokinetic characterization of controlled-release formulations. Eur. J. Drug Metab. Pharmacokinet. 15: 173-181.
2. Bois F.Y., Tozer T.N., Hauck W.W., Chen M.L., Patnaik R., Williams R.L. (1994): Bioequivalence: performance of several measures of rate of absorption. Pharm. Res. 11: 966-974.
3. Wong S.H.Y., McCauley T. (1981): Reversed phase high performance liquid Chromatographic analysis of tricyclic antidepressants in plasma. J. Liq. Chromatogr. 4: 849-862.
4. Martindale, The Extra Pharmacopoeia 29 ed., Reynolds JEF (editor). London, The Pharmaceutical Press 1989.
5. Schulz P., Dick P., Blaschke T.F., Hollister L. (1985): Discrepancies between pharmacokinetic studies of Amitriptyline. Clin. Pharmacokinet. 10: 257-268.
6. Vzquez M., Fagiolino P., Payss H., Rubio M., Aiache J.M., Mario E., Bioequivalence assessment from salivary data. Submitted.